October 7, 2025
1 min read

OXB kicks off US expansion, buying viral vector plant in N.C. from National Resilience for $4.5M

Less than two months after OXB revealed a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy manufacturer has purchased a viral vector plant in North Carolina from National Resilience for $4.5 million.

Leave a Reply

Your email address will not be published.

Previous Story

Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India

Strong Social Relationships Promote Longevity by Slowing Cellular Aging
Next Story

Strong Social Relationships Promote Longevity by Slowing Cellular Aging

Previous Story

Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India

Strong Social Relationships Promote Longevity by Slowing Cellular Aging
Next Story

Strong Social Relationships Promote Longevity by Slowing Cellular Aging

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop